Surescripts Approved as Alternative Test Method for EHRs to Achieve ONC Health IT Certification for E-Prescribing and Ambulatory Medication History Services

ARLINGTON, Va.–(BUSINESS WIRE)–#EHR–The Office of the National Coordinator for Health IT (ONC) has named Surescripts as an ONC Program Partner for Electronic Prescribing (45 C.F.R. § 170.315(b)(3)) and approved Surescripts as an alternative test method to the ONC-Authorized Testing Laboratory (ONC-ATL). Now, electronic health records (EHR) vendors who complete Surescripts certification testing for E-Prescribing or Medication History for Ambulatory may simultaneously achieve ONC Health IT certification for the National Council for Prescription Drug Programs’ (NCPDP) SCRIPT 10.6 standard.

“The addition of the Surescripts test method adds a new flexibility within the current alternative test method approval process, and lays the groundwork for future ONC-Surescripts collaboration,” said Steve Posnack, Deputy National Coordinator for Health IT at ONC. “Testing by ONC Program Partners provides additional streamlined pathways for health IT developers to demonstrate conformance with ONC Health IT Certification Program requirements in lieu of testing directly with an ONC-Authorized Testing Lab (ONC-ATL).”

This recent addition to the testing portfolio is in line with ONC’s goal to transition the ONC Health IT Certification Program’s testing portfolio to as many industry-developed and maintained testing tools as possible. The purpose of this goal is to more efficiently focus testing resources and better align with industry-developed testing tools to support real-world testing as envisioned by the 21st Century Cures Act.

ONC Health IT certification is required, as part of ONC’s 170.315 (b)(3) criterion and related standards, in order for prescribers to earn incentives and avoid penalties from the Centers for Medicare & Medicaid Services (CMS) based on their use of technology that facilitates electronic prescribing.

“We’ve worked closely with ONC for many years to align our certification requirements and ultimately deliver more value across the Surescripts Network Alliance,” said Mike Pritts, Chief Product Officer of Surescripts. “By removing duplicate testing requirements, we’ve helped EHRs streamline and speed up the certification process so they can focus on meeting the needs of their prescribers. As an ONC Program Partner, we expect to update this partnership as the transition to NCPDP SCRIPT v2017071 occurs next year.”

Surescripts E-Prescribing enhances the prescribing process by empowering prescribers and pharmacists with a streamlined workflow and more time with patients, who benefit from improved medication adherence, safety and efficiency. Surescripts supports standard e-prescribing transactions required by ONC. Surescripts Medication History for Ambulatory aggregates and delivers accurate medication histories into the ambulatory care workflow to inform e-prescribing.

EHRs who have already achieved ONC Health IT certification for 2015, in accordance with NCPDP SCRIPT standard 10.6, do not need to take any action. EHRs who have not already achieved certification for 2015 can use Surescripts test certificates as long as they are certified for all of the required message types.

Visit Surescripts.com to learn more about Surescripts certification and to find out which EHR vendors are certified for Surescripts E-Prescribing and Medication History solutions.

About Surescripts

Our purpose is to serve the nation with the single most trusted and capable health information network, built to increase patient safety, lower costs and ensure quality care. Since 2001, Surescripts has led the movement to turn data into actionable intelligence and convened the Surescripts Network Alliance™ to enhance prescribing, inform care decisions and advance the healthcare industry. Visit us at surescripts.com and follow us at twitter.com/surescripts.

Contacts

Kelly Jeffers

Surescripts

(571) 384-4776

kelly.jeffers@surescripts.com

Staff

Recent Posts

Massimo Group Signs Letter of Intent to Acquire 100% of AI technology company FST in Drive to Accelerate Its AI-Powered Mobility and Health Technology Strategy

GARLAND, Texas, Feb. 3, 2026 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO) ("Massimo" or the "Company"),…

2 hours ago

Baysient Launches iDose® GEN7.0, Expanding Precision Dosing Platform to 16 Inflammatory Disease Indications

Next-Generation Decision Support Software Introduces Predictive Clinical Tools for Gastroenterology, Rheumatology, Dermatology, and PulmonologyFORT MYERS,…

2 hours ago

From the Founders of Fitbit: Introducing Luffu, Your Guardian for Family Health & Safety

After making personal health accessible to millions with Fitbit, James Park and Eric Friedman announce…

2 hours ago

Embla Medical hf: Interim Report Q4 and Full Year 2025

COPENHAGEN, Denmark, Feb. 3, 2026 /PRNewswire/ -- Announcement no. 5/2026 Interim Report Q4 and Full…

2 hours ago

UAE Partners with Colossal Biosciences to Protect Biodiversity and Champion the Future of Life on Earth

The collaboration positions the UAE as a global leader in conservation, driving pioneering initiatives in…

2 hours ago

Case Reports in Regrowth Announces Publication of Muhammad Qasim Observational Case Report and Invites Medical Review

New York, New York--(Newsfile Corp. - February 3, 2026) - Case Reports in Regrowth today…

2 hours ago